Rosso R - Search Results

1

Lamivudine resistance mutations in European patients with hepatitis B and patients co-infected with HIV and hepatitis B.

Taramasso L, Caligiuri P, Di Biagio A, Bruzzone B, Rosso R, Icardi G, Viscoli C. Taramasso L, et al. Among authors: rosso r. J Med Virol. 2011 Nov;83(11):1905-8. doi: 10.1002/jmv.22192. J Med Virol. 2011. PMID: 21915864

2

Safety and efficacy of pegylated interferon and ribavirin in adolescents with human immunodeficiency virus and hepatitis C virus acquired perinatally.

Rosso R, Di Biagio A, Mikulska M, Nicco E, Bernardini C, Viscoli C. Rosso R, et al. J Med Virol. 2010 Jul;82(7):1110-4. doi: 10.1002/jmv.21802. J Med Virol. 2010. PMID: 20513072

3

Benign lymphoepithelial parotid lesions in vertically HIV-infected patients.

Rosso R, Pretolesi F, del Bono V, Buscaglia M, Ferrando S, Farinella ST, di Biagio A, Bassetti M, Derchi LE, Viscoli C. Rosso R, et al. AIDS Patient Care STDS. 2006 Aug;20(8):536-41. doi: 10.1089/apc.2006.20.536. AIDS Patient Care STDS. 2006. PMID: 16893322

4

Successful rescue therapy with Raltegravir (MK-0518) and Etravirine (TMC125) in an hiv-infected patient failing all four classes of antiretroviral drugs.

Di Biagio A, Bruzzone B, Rosso R, Viganò O, Icardi G, Viscoli C, Rusconi S. Di Biagio A, et al. Among authors: rosso r. AIDS Patient Care STDS. 2008 May;22(5):355-7. doi: 10.1089/apc.2007.0215. AIDS Patient Care STDS. 2008. PMID: 18373415 Free article. No abstract available.

5

Infectious complications of cancer chemotherapy in HIV patients.

Rosso R, Di Biagio A, Viscoli C. Rosso R, et al. Curr Infect Dis Rep. 2008 May;10(2):149-56. doi: 10.1007/s11908-008-0026-7. Curr Infect Dis Rep. 2008. PMID: 18462590

6

Efficacy and safety of darunavir and etravirine in an antiretroviral multi-experienced youth with vertically HIV-1 infection.

Rosso R, Bernardini C, Bruzzone B, Secondo G, Icardi G, Viscoli C, Di Biagio A. Rosso R, et al. Eur J Med Res. 2009 Mar 17;14(3):136-8. doi: 10.1186/2047-783x-14-3-136. Eur J Med Res. 2009. PMID: 19380285 Free PMC article.

7

Evaluation of insulin resistance in a cohort of HIV-infected youth.

Rosso R, Di Biagio A. Rosso R, et al. Curr Diab Rep. 2009 Aug;9(4):260-1. doi: 10.1007/s11892-009-0052-3. Curr Diab Rep. 2009. PMID: 19640337 No abstract available.

8

HIV and accelerated atheroprogression: role of antiretroviral therapy.

Di Biagio A, Del Bono V, Rosso R, Viscoli C. Di Biagio A, et al. Among authors: rosso r. Curr Pharm Biotechnol. 2012 Jan;13(1):88-96. doi: 10.2174/138920112798868520. Curr Pharm Biotechnol. 2012. PMID: 21470158

9

Patient-reported outcomes and low-level residual HIV-RNA in adolescents perinatally infected with HIV-1 after switching to one-pill fixed-dose regimen.

Rosso R, Di Biagio A, Maggiolo F, Nulvesu L, Callegaro AP, Taramasso L, Bruzzone B, Viscoli C. Rosso R, et al. AIDS Care. 2012;24(1):54-8. doi: 10.1080/09540121.2011.596511. Epub 2011 Jul 29. AIDS Care. 2012. PMID: 21800951

10

Nevirapine-based regimens in routine clinical settings: results from a large Italian cohort of HIV-1 infected adults.

Rosso R, Rossotti R, Di Biagio A, Nicolini L, Adorni F, Orani A, Viscoli C. Rosso R, et al. Curr Drug Saf. 2011 Jul;6(3):138-44. doi: 10.2174/157488611797579339. Curr Drug Saf. 2011. PMID: 22122388

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

866 results

Search Page

Filters